Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
56 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03839771 | A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy(HOVON150AML) | active not recruiting | Phase 3 | 968 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 15 | Sep 22, 2026 | clinicaltrials |
| NCT07500259 | Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC(COLOPan) | recruiting |
| — |
| 188 |
| Luxembourg Institute of HealthOTHER_GOV |
| 1 |
| Sep 15, 2026 |
| clinicaltrials |
| NCT02102165 | AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.(AURORA) | recruiting | N/A | 1,000 | Jules Bordet InstituteOTHER | 10 | Aug 6, 2026 | clinicaltrials |
| NCT05563220 | Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer(ELEVATE) | active not recruiting | Phase 1 / Phase 2 | 435 | Stemline Therapeutics, Inc.INDUSTRY | 13 | Jun 12, 2026 | clinicaltrials |
| NCT03771859 | A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed | completed | — | 152 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 2, 2026 | clinicaltrials |
| NCT05874492 | Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer(FIBROTHERME) | recruiting | N/A | 110 | Association Francaise pour la Recherche ThermaleOTHER | 2 | Apr 13, 2026 | clinicaltrials |
| NCT01208766 | Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma(HO95) | completed | Phase 3 | 1,503 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 16 | Jan 6, 2026 | clinicaltrials |
| NCT04109131 | A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours(BrainStorm) | recruiting | N/A | 600 | Jules Bordet InstituteOTHER | 3 | Jan 6, 2026 | clinicaltrials |
| NCT02141438 | Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer(REASSURE) | completed | — | 1,472 | BayerINDUSTRY | 20 | Oct 16, 2025 | clinicaltrials |
| NCT03997617 | Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg. | completed | N/A | 57 | Luxembourg Institute of HealthOTHER_GOV | 1 | Jun 13, 2025 | clinicaltrials |
| NCT01945762 | Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer(Caprelsa104) | completed | — | 31 | Genzyme, a Sanofi CompanyINDUSTRY | 8 | Dec 18, 2024 | clinicaltrials |
| NCT03191786 | A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy(IPSOS) | completed | Phase 3 | 453 | Hoffmann-La RocheINDUSTRY | 24 | Oct 23, 2024 | clinicaltrials |
| NCT03386929 | Survival Prolongation by Rationale Innovative Genomics(SPRING) | terminated | Phase 1 / Phase 2 | 15 | Worldwide Innovative Network AssociationOTHER | 4 | Dec 18, 2023 | clinicaltrials |
| NCT05324020 | eHealth Intervention for Medication Adherence in Breast Cancer Survivors(Edherence) | completed | N/A | 3 | Luxembourg Institute of HealthOTHER_GOV | 1 | Sep 7, 2023 | clinicaltrials |
| NCT00858364 | Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | terminated | Phase 3 | 2,549 | AmgenINDUSTRY | 37 | Nov 30, 2022 | clinicaltrials |
| NCT05138094 | LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection(LIVACOR) | unknown | N/A | 82 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 10 | Jul 25, 2022 | clinicaltrials |
| NCT03199144 | Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer(CKPancreas) | withdrawn | Phase 2 | 0 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT03209128 | Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala(IPC) | terminated | — | 11 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT04948840 | Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis(TREM-1) | unknown | N/A | 20 | Centre Francois Baclesse, LuxembourgOTHER | 2 | Jun 23, 2022 | clinicaltrials |
| NCT03206385 | IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume(Boost_Pelvis) | unknown | — | 120 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT03235557 | CyberKnife for Prostate Cancer Patients Aged 70 y or More(ProRobot) | completed | — | 150 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT03284151 | Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma | unknown | — | 26 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT03286023 | Stereotactic Radiotherapy for Brain Metastases(CKBrainMeta) | unknown | — | 110 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT01702571 | A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment | completed | Phase 3 | 2,185 | Hoffmann-La RocheINDUSTRY | 43 | Apr 4, 2022 | clinicaltrials |
| NCT04648319 | A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma | terminated | Phase 2 | 1 | American University of Beirut Medical CenterOTHER | 3 | Feb 23, 2022 | clinicaltrials |
| NCT03249584 | OsteoCool Tumor Ablation Post-Market Study(OPuS One) | completed | N/A | 218 | MedtronicNeuroINDUSTRY | 5 | Oct 1, 2021 | clinicaltrials |
| NCT02737501 | ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants(ALTA-1L) | completed | Phase 3 | 275 | Ariad PharmaceuticalsINDUSTRY | 19 | Aug 20, 2021 | clinicaltrials |
| NCT01235962 | A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)(PROTECT) | completed | Phase 3 | 1,538 | Novartis PharmaceuticalsINDUSTRY | 26 | Nov 23, 2020 | clinicaltrials |
| NCT02671422 | LUME BioNIS: a Biomarker Study in Patients With NSCLC | completed | — | 260 | Boehringer IngelheimINDUSTRY | 13 | Sep 24, 2020 | clinicaltrials |
| NCT02236637 | A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care | completed | — | 3,050 | Janssen Pharmaceutica N.V., BelgiumINDUSTRY | 15 | Nov 12, 2019 | clinicaltrials |
| NCT00349089 | Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy | completed | Phase 2 | 132 | Thoraxklinik-Heidelberg gGmbHOTHER | 3 | Sep 19, 2019 | clinicaltrials |
| NCT01381874 | A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy | completed | Phase 2 | 297 | Janssen Research & Development, LLCINDUSTRY | 12 | Apr 11, 2019 | clinicaltrials |
| NCT01856101 | Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy(BEZ235) | terminated | Phase 2 | 22 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | Apr 10, 2019 | clinicaltrials |
| NCT03210129 | Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients(MIPAClux) | completed | N/A | 25 | Luxembourg Institute of HealthOTHER_GOV | 1 | Mar 14, 2019 | clinicaltrials |
| NCT01147562 | Biomarker Discovery and Validation in Lung Cancer(LCS) | unknown | N/A | 150 | Dr. Guy BerchemOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT02785900 | Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia(CASCADE) | terminated | Phase 3 | 240 | Seagen Inc.INDUSTRY | 16 | Dec 12, 2018 | clinicaltrials |
| NCT01801111 | A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment | completed | Phase 1 / Phase 2 | 138 | Hoffmann-La RocheINDUSTRY | 16 | Nov 2, 2018 | clinicaltrials |
| NCT02042144 | Safety and Effectiveness of Regorafenib(Correlate) | completed | — | 1,034 | BayerINDUSTRY | 13 | Jan 16, 2018 | clinicaltrials |
| NCT01154140 | A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung(PROFILE 1014) | completed | Phase 3 | 343 | PfizerINDUSTRY | 31 | Nov 6, 2017 | clinicaltrials |
| NCT01528163 | Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck(RACATREX) | completed | Phase 2 | 101 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | Jun 14, 2017 | clinicaltrials |
| NCT00182819 | Radiation Therapy or Temozolomide in Treating Patients With Gliomas | completed | Phase 3 | 709 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 19 | Oct 12, 2016 | clinicaltrials |
| NCT00021450 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | Phase 3 | 819 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 2, 2016 | clinicaltrials |
| NCT00338247 | EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | approved for marketing | — | — | NovartisINDUSTRY | 45 | Apr 6, 2016 | clinicaltrials |
| NCT01161173 | An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer(TEAM) | completed | — | 347 | Hoffmann-La RocheINDUSTRY | 2 | Mar 28, 2016 | clinicaltrials |
| NCT01082549 | Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)(ECLIPSE) | completed | Phase 3 | 780 | SanofiINDUSTRY | 14 | Mar 17, 2016 | clinicaltrials |
| NCT02495051 | Esophageal Atresia: Metaplasia, Barrett(Oesophagix) | completed | — | 120 | University Hospital, LilleOTHER | 4 | Jul 13, 2015 | clinicaltrials |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | completed | Phase 3 | 984 | SanofiINDUSTRY | 29 | Jan 21, 2015 | clinicaltrials |
| NCT00431769 | An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma | completed | Phase 2 | 130 | Janssen-Cilag International NVINDUSTRY | 8 | May 12, 2014 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials